Dragonfly Biosciences signs distribution agreement with AM Mangion Group
11th September 2018
Dear Shareholders and Partners,

Dragonfly Biosciences is delighted to announce it has entered into a distribution agreement with established leading pharmaceutical distribution group AM Mangion. Founded by the Chairman, Alfred M Mangion in 1978, it is one of the healthcare sector's leading distributors.

The strength of the A.M.Mangion Group is their local set up, accompanied by the high quality principals it represents. A.M.Mangion offer services relating to Marketing and Sales, Importation and Distribution, Regulatory, Quality and PV.
This agreement is is for the Maltese Islands and other territories in North Africa and Southern Europe, and will involve a range of CBD products.

We are excited about this opportunity and look forward to updating our shareholders and partners as our sales grow.

Kind regards,

Chris Wronski
Chairman, Dragonfly Biosciences Ltd.

Our Products
Copyright © 2018 Dragonfly Biosciences Ltd, All rights reserved.